S1P/S1PR轴在银屑病关节炎炎症与结构损伤中的作用:临床、生化与影像学相关性横断面研究
该横断面研究纳入21名健康对照和43例银屑病关节炎(PsA)患者(16例近期起病、27例 established PsA),检测血清S1P与S1PR水平并评估临床活动度、骨密度及影像学炎症与结构损伤。结果示PsA组S1P显著高于对照(p=0.013),established PsA亚组最高(p=0.009);S1PR在超声跟腱附着点炎(p=0.046)及骨增生/结构损伤(p=0.03)患者中显著升高。结论提示S1P/S1PR轴失调与PsA疾病进展相关,可能作为结构损伤生物标志物及治疗靶点。
要点
- PsA患者血清S1P显著高于健康对照,established PsA亚组最高。
- S1PR水平在超声跟腱附着点炎及骨增生/结构损伤患者中显著升高。
- S1P/S1PR轴可能与附着点骨免疫学及结构损伤相关。
核心结论
- S1P/S1PR轴在PsA中失调并与疾病进展相关,其与超声附着点炎及新骨形成的相关性提示S1P是附着点骨免疫学的关键介质,可能作为结构损伤的生物标志物和新治疗靶点。
研究设计与样本
- 横断面观察性研究,纳入64名受试者:21名健康对照和43例PsA患者(16例近期起病PsA和27例established PsA)。
- 评估临床变量包括DAPSA、骨密度、骨小梁评分、3D-Shaper,以及多普勒超声和MRI评估的炎症活动度;采用ELISA检测S1P和S1PR水平。
主要发现
- PsA组S1P水平显著高于对照组(p=0.013),established PsA亚组S1P值最高(p=0.009)。
- S1P与DAPSA评分无显著相关性。
- 超声检出跟腱附着点炎的患者S1PR水平显著更高(p=0.046)。
- 存在骨增生/结构损伤的患者S1PR水平显著更高(p=0.03)。
- established PsA患者皮质容积骨密度显著高于对照组(p=0.027)。
临床怎么用
- S1P/S1PR轴可能作为评估PsA结构损伤进展的潜在生物标志物。
- S1P/S1PR轴或为PsA附着点炎及骨增生提供新的治疗靶点方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease with a complex clinical spectrum. Sphingosine-1-phosphate (S1P) and its receptor (S1PR) are key lipid mediators involved in immunity and bone remodelling. This study evaluates the inter-relationship between serum levels of S1P and S1PR and clinical activity, radiological findings and different stages of PsA. METHODS: A cross-sectional observational study was conducted including 64 subjects: 21 healthy controls and 43 patients with PsA: 16 with recent-onset PsA and 27 with established PsA (EPsA). Clinical variables such as disease activity in PsA (DAPSA), bone mineral density (BMD), Trabecular Bone Score, 3D-Shaper and inflammatory activity by Doppler ultrasound and MRI were assessed. S1P and S1PR levels were measured by ELISA. RESULTS: S1P levels were significantly higher in the PsA group compared with controls (p=0.013), with the highest values observed in the EPsA subgroup (p=0.009). Although no significant correlation was observed with the DAPSA Score, S1PR levels were significantly higher in patients with Achilles enthesitis detected by ultrasound (p=0.046) and in those with bone proliferation/structural damage (p=0.03). Patients with EPsA showed significantly higher cortical volumetric BMD compared with controls (p=0.027). CONCLUSIONS: The S1P/S1PR axis is dysregulated in PsA and is associated with disease progression. Its correlation with ultrasound findings of enthesitis and new bone formation suggests that S1P acts as a critical mediator in the osteoimmunology of the enthesis, positioning it as a potential biomarker of structural damage and a novel therapeutic target.
引用
- Ruiz-Montesinos D, Mendoza-Mendoza D, Bocio Núñez J, et al. Role of the S1P/S1PR axis in inflammation and structural damage in psoriatic arthritis: a cross-sectional study with clinical, biochemical and imaging correlation. RMD Open. 2026. PMID: 42259576. doi:10.1136/rmdopen-2026-006874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。